Epub 2011 Nov 1
Although much more research is needed to prove a direct causal relationship between GLP-1 drugs and cancer reduction, the findings offer promise as a potential public health tool for cancer risk
In some cases, alternative treatments with fewer metabolic effects might be appropriate, or the timing of therapies could be optimised to minimise conflicting effects whilst maintaining therapeutic benefit
The Clinical Perspective: Experience Matters In our clinical experience at Revolution Health & Wellness , patients who use both forms strategically tend to achieve the best long-term results: Those with GI complaints (bloating, food reactivity, IBS, reflux) often respond best to oral BPC-157 first, then may transition to injectables later
This includes enhanced insulin secretion in response to elevated blood glucose, suppression of glucagon release , and delayed gastric emptying